Western Regional Blog – BC, YK, AB, NWT and Nunavut
Roche Canada will be applying for approval from Health Canada in the near future for the use of Avastin for women with recurrent ovarian cancer.
As a component of the approval process, Ovarian Cancer Canada has the opportunity to submit testimonials from patients. In order to prepare this submission, we are looking for women who have had recurrent ovarian cancer and who have been treated with Avastin.
We are also looking for women (or their caregivers) who wanted to take Avastin but were not able or ineligible.
The survey for women living with ovarian cancer can be found athttp://www.surveymonkey.com/s/ovcatreatment
The survey for caregivers can be found athttp://www.surveymonkey.com/s/ovcatreatmentcare
If you are one of these women and would like to assist in this submission, please contact Kelly Grover by email at firstname.lastname@example.org or by phone at 1-877-413-7970, ext. 273 as soon as possible.
More information on the Roche Patient Assistance Program.